U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907328) titled 'FUS Neuromodulation for Binge Eating Disorder' on Oct. 09.
Brief Summary: This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of FUS neuromodulation in patients with Binge Eating Disorder (BED)
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Binge-Eating Disorder
Intervention:
DEVICE: LIFU Neuromodulation
Subjects will undergo a single LIFU of the target brain region
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ali Rezai
Information provided by (Responsible Party): Ali Rezai, West Virginia University
Published by HT Digital Content Serv...